Medical Faculty, University of Bern, Bern, Switzerland.
Centre on Aging and Mobility, Department of Geriatrics and Aging Research, University of Zurich, Zurich, Switzerland.
Clin Interv Aging. 2024 May 30;19:993-1003. doi: 10.2147/CIA.S463917. eCollection 2024.
Muscle ultrasound has emerged as a promising method in the diagnostic work-up of sarcopenia. The objective of this scoping review was to explore the validity of muscle ultrasound against the latest sarcopenia definitions among older adults.
We adhered to the PRISMA guidelines for scoping reviews. A systematic search of databases was performed by two independent reviewers. All articles comparing the performance of ultrasound to an internationally acknowledged sarcopenia definition among older adults (≥60 years) and published between 2019/01/01 (the year updated sarcopenia definitions were introduced) and 2023/11/15 were included. Data were extracted and collated by muscle and muscle parameters.
Out of 2290 articles screened, six studies comprising 24 validity tests among a total of 1619 older adults (mean age 74.1 years, 52.2% female) were included. The validity tests investigated the rectus femoris (n = 7), biceps brachii (n = 5), gastrocnemius medialis (n = 4), tibialis anterior (n = 4), soleus (n = 3), and rectus abdominis (n = 1). The parameter muscle thickness (MT) (n = 14) was most commonly measured. The latest European and Asian sarcopenia definitions (EWGSOP2, AWGS2) were applied as reference standards in four validity tests each. None of the studies used the Sarcopenia Definition and Outcome Consortium (SDOC) criteria. The highest area under the curve AUC (0.92, 95% confidence interval [CI] 0.89-0.94) was found for the muscle thickness of the rectus femoris muscle. Due to substantial heterogeneity among the studies, pooling of data using a meta-analytic approach was not feasible.
Limited number of studies have examined the validity of muscle ultrasound for diagnosing sarcopenia based on recent definitions among older adults. Thereby, muscle thickness of the rectus femoris showed promising results regarding validity. Further studies are needed to investigate the validity of key muscles and to validate muscle ultrasound among older hospitalized patients.
肌肉超声已成为诊断肌少症的一种很有前途的方法。本综述的目的是探讨肌肉超声对老年人最新肌少症定义的有效性。
我们遵循 PRISMA 指南进行综述。两位独立的审查员对数据库进行了系统搜索。所有比较超声与老年人(≥60 岁)公认的肌少症定义之间表现的文章均被纳入,纳入时间为 2019 年 1 月 1 日(更新肌少症定义的年份)至 2023 年 11 月 15 日。数据由肌肉和肌肉参数提取和整理。
在筛选出的 2290 篇文章中,纳入了 6 项研究,共涉及 24 项有效性测试,共有 1619 名老年人(平均年龄 74.1 岁,52.2%为女性)参与。有效性测试分别对股直肌(n=7)、肱二头肌(n=5)、腓肠肌内侧(n=4)、胫骨前肌(n=4)、比目鱼肌(n=3)和腹直肌(n=1)进行了研究。最常测量的参数是肌肉厚度(MT)(n=14)。四项有效性测试中,每项均采用最新的欧洲和亚洲肌少症定义(EWGSOP2、AWGS2)作为参考标准。没有一项研究使用肌少症定义和结果联合会(SDOC)标准。股直肌肌肉厚度的曲线下面积 AUC 最高(0.92,95%置信区间[CI]0.89-0.94)。由于研究之间存在很大的异质性,因此无法使用荟萃分析方法对数据进行汇总。
基于老年人的最新定义,有限数量的研究已经检验了肌肉超声诊断肌少症的有效性。因此,股直肌的肌肉厚度在有效性方面显示出了有希望的结果。需要进一步的研究来验证关键肌肉的有效性,并在老年住院患者中验证肌肉超声。